Catechin-7-O-β-D-glucopyranoside isolated from the seed of Phaseolus calcaratus Roxburgh ameliorates experimental colitis in rats

International Immunopharmacology

Volumn 29, Issue 2, 2015, Pages 521-527

  Kook, Sung Ho ^a   Choi, Ki Choon ^b   Cho, Seong Wan ^c   Cho, Hyoung Kwon ^d   Lee, Kyung Dong ^e   Lee, Jeong Chae ^a  

^a Chonbuk National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Konyang University   (South Korea)

^d Han Poong Pharmaceutical Co Ltd   (South Korea)

^e Dongshin University   (South Korea)

Author keywords

Catechin 7 O d glucopyranoside; Intestinal anti inflammation; Phaseolus calcaratus R; Ulcerative colitis

Indexed keywords

BUTANOL; CATECHIN 7 O BETA DEXTRO GLUCOPYRANOSIDE; CYCLOOXYGENASE 2; DNA NUCLEAR FACTOR KAPPA B; GLUCOPYRANOSIDE; GLUTATHIONE; I KAPPA B ALPHA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MALONALDEHYDE; MESALAZINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN 2; MUCIN 3; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; PHASEOLUS CALCARATUS EXTRACT; PLANT EXTRACT; PROTEIN; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CATECHIN; CATECHIN 7-O-GLUCOPYRANOSIDE; GLUCOSIDE; MUCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLON; CONTROLLED STUDY; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXPERIMENTAL COLITIS; EXPERIMENTAL MODEL; MALE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RICE BEAN; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; CHEMICALLY INDUCED; CHEMISTRY; CROHN DISEASE; DRUG EFFECTS; GENE EXPRESSION REGULATION; ISOLATION AND PURIFICATION; METABOLISM; PHASEOLUS; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY WEIGHT; CATECHIN; CROHN DISEASE; GENE EXPRESSION REGULATION; GLUCOSIDES; GLUTATHIONE; MALE; MALONDIALDEHYDE; MUCINS; PEROXIDASE; PHASEOLUS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEEDS; TRINITROBENZENESULFONIC ACID;

EID: 84948446679     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.10.003     Document Type: Article

References (30)

1. M.G. Neuman Immune dysfunction in inflammatory bowel disease Transl. Res. 149 2007 173 186
2. Y.H. Kho, M.O. Pool, F.G. Jansman, and J.W. Harting Pharmacotherapeutic options in inflammatory bowel disease: an update Pharm. World Sci. 23 2001 17 21
3. B. Ngo, C.P. Farrell, M. Barr, K. Wolov, R. Bailey, J.M. Mullin, and J.J. Thornton Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety Curr. Mol. Pharmacol. 3 2010 145 152
4. R.B. Stein, and S.B. Hanauer Comparative tolerability of treatments for inflammatory bowel disease Drug Saf. 23 2000 429 448
5. S. Ben-Horin, and Y. Chowers Tailoring anti-TNF therapy in IBD: drug levels and disease activity Nat. Rev. Gastroenterol. Hepatol. 11 2014 243 255
6. H. Yanai, L. Lichtenstein, A. Assa, Y. Mazor, B. Weiss, A. Levine, Y. Ron, U. Kopylov, Y. Bujanover, Y. Rosenbach, B. Ungar, R. Eliakim, Y. Chowers, R. Shamir, G. Fraser, I. Dotan, and S. Ben-Horin Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab Clin. Gastroenterol. Hepatol. 13 2015 522 530
7. A.V. Weizman, E. Ahn, R. Thanabalan, W. Leung, K. Croitoru, M.S. Silverberg, A.H. Steinhart, and G.C. Nguyen Characterization of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease Aliment. Pharmacol. Ther. 35 2012 342 349
8. F. Algieri, P. Zorrilla, A. Rodriguez-Nogales, N. Garrido-Mesa, O. Bañuelos, M.R. González-Tejero, M. Casares-Porcel, J. Molero-Mesa, A. Zarzuelo, M.P. Utrilla, M.E. Rodriguez-Cabezas, and J. Galvez Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis J. Ethnopharmacol. 146 2013 750 759
9. Q.W. Zhao, X. Huang, Y.J. Lou, N. Weber, and P. Proksch Effects of ethanol extracts from Adzuki bean (Phaseolus angularis Wight.) and Lima bean (Phaseolus lunatus L.) on estrogen and progesterone receptor phenotypes of MCF-7/BOS cells Phytother. Res. 21 2007 648 652
10. M. Fang, S.Y. Lee, S.M. Park, K.C. Choi, Y.J. Lee, H.K. Cho, S.W. Cho, W.K. Whang, and J.C. Lee Anti-inflammatory potential of Phaseolus calcaratus Roxburgh, an oriental medicine, on LPS-stimulated RAW 264.7 macrophages J Pharm Pharmacol 63 2011 120 128
11. S. Park, K.C. Choi, M. Fang, Y.C. Lim, Y.M. Jeon, and J.C. Lee Red bean extract reduces inflammation and increases survival in a murine sepsis model Food Sci. Biotechnol. 20 2011 1125 1131
12. 2-mediated oxidative stress Food Sci. Biotechnol. 20 2011 151 158
13. D. Camuesco, L. Peran, M. Comalada, A. Nieto, L.C. Di Stasi, M.E. Rodriguez-Cabezas, A. Concha, A. Zarzuelo, and J. Galvez Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis Inflamm. Bowel Dis. 11 2005 265 271
14. M.M. Nagib, M.G. Tadros, M.I. ElSayed, and A.E. Khalifa Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats Toxicol. Appl. Pharmacol. 271 2013 106 113
15. B. Arribas, E. Suárez-Pereira, C. Ortiz Mellet, J.M. García Fernández, C. Buttersack, M.E. Rodríguez-Cabezas, N. Garrido-Mesa, E. Bailon, E. Guerra-Hernández, A. Zarzuelo, and J. Gálvez Di-D-fructose dianhydride-enriched caramels: effect on colon microbiota, inflammation, and tissue damage in trinitrobenzenesulfonic acid-induced colitic rats J. Agric. Food Chem. 58 2010 6476 6484
16. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
17. ∅. Brenna, M.W. Furnes, I. Drozdov, G.A. van Beelen, A. Flatberg, A.K. Sandvik, R.T. Zwiggelaar, R. Mårvik, I.S. Nordrum, M. Kidd, and B.I. Gustafsson Relevance of TNBS-colitis in rats: a methodological study with endoscopic, historical and transcriptomic characterization and correlation to IBD PLoS One 8 2013 e54543
18. H. González-Mauraza, C. Martín-Cordero, C. Alarcón-de-la-Lastra, M.A. Rosillo, A.J. León-González, and M. Sánchez-Hidalgo Anti-inflammatory effects of Retama monosperma in acute ulcerative colitis in rats J. Physiol. Biochem. 70 2014 163 172
19. C.G. Peterson, P. Sangfelt, M. Wagner, T. Hansson, H. Lettesjö, and M. Carlson Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis Scand. J. Clin. Lab. Invest. 67 2007 810 820
20. G.S. Youn, D.J. Kwon, S.M. Ju, S.Y. Choi, and J. Park Curcumin ameliorates TNF-α-induced ICAM-1 expression and subsequent THP-1 adhesiveness via the induction of heme oxygenases-1 in the HaCa T cells BMB Rep. 46 2013 410 415
21. K.M. Tytgat, F.J. Bovelander, F.J. Opdam, A.W. Einerhand, H.A. Büller, and J. Dekker Biosynthesis of rat MUC2 in colon and its analogy with human MUC2 Biochem. J. 309 1995 221 229
22. L. Su, L. Shen, D.R. Clayburgh, S.C. Nalle, E.A. Sullivan, J.B. Meddings, C. Abraham, and J.R. Turner Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis Gastroenterology 136 2009 551 563
23. M.J. Sung, M. Davaatseren, W. Kim, S.K. Park, S.H. Kim, H.J. Hur, M.S. Kim, Y.S. Kim, and D.Y. Kwon Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-kappaB activation in RAW 264.7 cells Int. Immunopharmacol. 9 2009 319 323
24. P.M. O'Connor, T.K. Lapointe, P.L. Beck, and A.G. Buret Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease Inflamm. Bowel Dis. 16 2010 1411 1420
25. D. Hommes, B. van den Blink, T. Plasse, J. Bartelsman, C. Xu, B. Macpherson, G. Tytgat, M. Peppelenbosch, and S. Van Deventer Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease Gastroenterology 122 2002 7 14
26. A. Wullaert, M.C. Bonnet, and M. Pasparakis NF-κB in the regulation of epithelial homeostasis and inflammation Cell Res. 21 2011 146 158
27. M.A. Rosillo, M. Sanchez-Hidalgo, and A. Cárdeno Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease Biochem. Pharmacol. 82 2011 737 745
28. I. Koboziev, F. Karlsson, S. Zhang, and M.B. Grisham Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies Inflamm. Bowel Dis. 17 2011 1229 1245
29. F. Powrie, M.W. Leach, S. Mauze, L.B. Caddle, and R.L. Coffman Phenotypically distinct subsets of CD4 + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice Int. Immunol. 5 1993 1461 1471
30. A.A. te Velde, F. de Kort, E. Sterrenburg, I. Pronk, F.J. ten Kate, D.W. Hommes, and S.J. van Deventer Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease Inflamm. Bowel Dis. 13 2007 325 330